First Thing, Daily Maverick's flagship newsletter

Join the 230 000 South Africans who read First Thing newsletter.

We'd like our readers to start paying for Daily Maverick

More specifically, we'd like those who can afford to pay to start paying. What it comes down to is whether or not you value Daily Maverick. Think of us in terms of your daily cappuccino from your favourite coffee shop. It costs around R35. That’s R1,050 per month on frothy milk. Don’t get us wrong, we’re almost exclusively fuelled by coffee. BUT maybe R200 of that R1,050 could go to the journalism that’s fighting for the country?

We don’t dictate how much we’d like our readers to contribute. After all, how much you value our work is subjective (and frankly, every amount helps). At R200, you get it back in Uber Eats and ride vouchers every month, but that’s just a suggestion. A little less than a week’s worth of cappuccinos.

We can't survive on hope and our own determination. Our country is going to be considerably worse off if we don’t have a strong, sustainable news media. If you’re rejigging your budgets, and it comes to choosing between frothy milk and Daily Maverick, we hope you might reconsider that cappuccino.

We need your help. And we’re not ashamed to ask for it.

Our mission is to Defend Truth. Join Maverick Insider.

Support Daily Maverick→
Payment options

US fears spur Ebola breakthrough



US fears spur Ebola breakthrough

It’s hard to make sense of all the medical jargon, but the conclusion is clear and potentially life-saving. Researchers in America have released a report saying they might just have found a cure for one of the world’s most dangerous diseases, the dreaded Ebola virus. Testing is still in its initial phases, but results are promising – and we have the US government to thank. By SIMON ALLISON.

The Ebola virus might not kill the most people. Outbreaks, while vicious, affect hundreds rather than millions, and it tends to die out (temporarily, at least) relatively quickly. But when it does strike, it strikes hard, killing up to 90% of the people it infects and afflicting them with the most horrifying symptoms, including hemorrhagic fever which causes bleeding from the eyes, nose, gums and intestines. It’s also highly contagious, making it extremely difficult to control.

It was these qualities that led the US government to take an active interest in finding some kind of vaccine for the disease. It wasn’t particularly worried about the African villagers who bear the brunt of outbreaks, every few years. Rather, in the wake of 9/11, they were terrified by the prospect of Ebola being used in some kind of terrorist attack. It would be a perfect fit: quick, lethal and terrifying in the extreme.

The intense research sparked by this fear looks like it might have paid off after scientists funded by the US government announced an important breakthrough. A new vaccine tested on mice yielded good results, with 80% of the infected mice surviving the infection. Although this finding comes with caveats – the strain of Ebola in mice differs from that in humans, and there are plenty more tests still to be performed – it’s still good news. And, at the same time, the scientists involved have pioneered a new way to produce the vaccine by growing it in modified tobacco plants. This will bring down the cost of the final drug considerably. DM

Read more:



Please peer review 3 community comments before your comment can be posted